Congruence Therapeutics Stock

Congruence Therapeutics operates as a biotechnology company.

Sign up today and learn more about Congruence Therapeutics Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Congruence Therapeutics Stock

Congruence Therapeutics operates as a biotechnology company working at the interface of computational and experimental drug discovery to design novel small molecules for diseases of protein misfolding.

Funding History

February 2022$63.0M
March 2023$15.0M

Press

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo